Biography:
Nurul Ain is a registered pharmacist and a final-year PhD candidate at the University of Manchester, specializing in drug delivery systems. Her current research focuses on the design of membrane-active peptides for targeted anticancer therapy. During her master’s study, she published three papers as the primary author, including work on nanoparticle formulations for oral cancer treatment and gel formulations for oral cancer applications
Title : Design and computational analysis of a peptide analogue with a WXXW motif: A membrane-active and reversible drug binding peptide to overcome cancer drug resistance